If lymph node involvement is tested in a client going through neoadjuvant therapy who is a potential candidate for focused axillary dissection (TAD), a marker need to be inserted in the lymph node right after biopsy. With regard to question two, from several analyses on the location of area https://glennx964uck2.blog-mall.com/profile